Federal Register / Vol. 88, No. 173 / Friday, September 8, 2023 / Notices 62097 

approximately 1 week after the public 

meeting. 

FDA has verified the website 

addresses in this document, as of the 

date this document publishes in the 

Federal Register, but websites are 

subject to change over time. 

Transcripts: Please be advised that as 

soon as a transcript of the public 

meeting is available, it will be accessible 

at https://www.regulations.gov. A link to 

the transcript will also be available at 

https://www.fda.gov/about-fda/officeimmunology-and-inflammationdivision-rheumatology-and-transplantmedicine-drtm. 

Dated: September 1, 2023. 

Lauren K. Roth, 

Associate Commissioner for Policy. 

[FR Doc. 2023–19405 Filed 9–7–23; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Advisory Council on Blood Stem Cell 

Transplantation 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services. 

ACTION: Notice. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, this 

notice announces that the Secretary’s 

Advisory Council on Blood Stem Cell 

Transplantation (ACBSCT or Advisory 

Council) has scheduled public meetings. 

Information about the Advisory Council 

and the agenda for these meetings can 

be found on the ACBSCT website at: 

https://bloodstemcell.hrsa.gov/about/ 

advisory-council. 

DATES: Thursday, September 28, 2023, 

2:00 p.m.–6:00 p.m. Eastern Standard 

Time; and Thursday, October 26, 2023, 

2:00 p.m.–6:00 p.m. Eastern Standard 

Time. 

ADDRESSES: Both meetings will be held 

virtually by webinar. A link to register 

and join each meeting will be posted at 

least 10 days prior to the meeting date 

at: https://bloodstemcell.hrsa.gov/ 

about/advisory-council. 

FOR FURTHER INFORMATION CONTACT: 

Shelley Tims Grant, Designated Federal 

Official, at the HRSA Health Systems 

Bureau, Division of Transplantation, 

5600 Fishers Lane, 8W–67, Rockville, 

MD 20857; 301–443–8036; or 

ACBSCTHRSA@hrsa.gov. 

SUPPLEMENTARY INFORMATION: The 

Advisory Council provides advice and 

recommendations to the Secretary of 

Health and Human Services on policy, 

program development, and other 

matters of significance concerning the 

activities under the authority of 42 

U.S.C. 274k (section 379 of the Public 

Health Service Act), as amended, and 

Public Law 109–129, as amended. The 

Advisory Council may transmit its 

recommendations through the 

Administrator of HRSA on matters 

related to the activities of the C.W. Bill 

Young Cell Transplantation Program 

and National Cord Blood Inventory. 

The agenda for the September 28, 

2023, meeting is being finalized and 

may include the following topics: the 

Department of Health and Human 

Services’ periodic review of the state of 

the science of using adult stem cells and 

birthing tissues to develop new types of 

therapies for patients, for the purpose of 

considering potential inclusion of such 

new therapies in the C.W. Bill Young 

Cell Transplantation Program; criteria 

for defining a high-quality cord blood 

unit for banking specifications; the 

unmet needs in blood stem cell 

transplantation and cellular therapy; 

strategies to improve rates of donation 

for adult blood stem cell donors; and 

other areas to increase blood stem cell 

donation and transplantation. The 

agenda for the October 26, 2023, 

meeting will be determined based on 

discussion, priorities, and/or action 

items from the September 28, 2023 

meeting. All agenda items will be 

posted on the Advisory Council’s 

website no later than 10 days prior to 

the respective meeting dates. Agenda 

items are subject to change as priorities 

dictate. Refer to the Advisory Council’s 

website for any updated information 

concerning the meeting. Members of the 

public will have the opportunity to 

provide comments. Public participants 

may submit written statements in 

advance of the scheduled meetings; oral 

comments will be honored in the order 

they are requested and may be limited 

as time allows. Requests to submit a 

written statement or make oral 

comments to the Advisory Council 

should be sent to Shelley Tims Grant, 

using the contact information above at 

least 3 business days prior to the 

meeting. Individuals who plan to attend 

and need special assistance or other 

reasonable accommodations should 

notify the Advisory Council at the 

address and phone number listed above 

at least 10 business days prior to the 

meeting. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2023–19398 Filed 9–7–23; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Amended Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Advisory 

Council on Drug Abuse, September 12, 

2023, 10:30 a.m. to September 12, 2023, 

05:00 p.m., National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 which 

was published in the Federal Register 

on August 21, 2023, FR Doc 2023– 

17889, 88 FR 56847. 

This notice is being amended to 

change the open session start time from 

12:45 p.m. to 1:00 p.m. The open 

session will now be held from 1:00 p.m. 

to 5:00 p.m. on September 12, 2023. The 

meeting is partially closed to the public. 

Dated: September 1, 2023. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–19406 Filed 9–7–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Notice of Meeting for the 

Interdepartmental Serious Mental 

Illness Coordinating Committee 

(ISMICC) 

AGENCY: Substance Abuse and Mental 

Health Services Administration, 

Department of Health and Human 

Services. 

ACTION: Notice. 

SUMMARY: The Secretary of Health and 

Human Services announces a meeting of 

the Interdepartmental Serious Mental 

Illness Coordinating Committee 

(ISMICC). 

The meeting will provide information 

on federal efforts related to serious 

mental illness (SMI) and serious 

emotional disturbance (SED). 

DATES: October 18, 2023, 10:00 a.m. to 

4:00 p.m. (EDT)/Open. 

ADDRESSES: The meeting is open to the 

public and can be accessed virtually 

only by accessing: https://

www.zoomgov.com/j/1608742409?

pwd=NjdoRlpGU2NoOH

paTzZVWXR3N0k4UT09, or by dialing 

646–828–7666, webinar ID: 160 874 

2409, passcode: 446018. Agenda with 

call-in information will be posted on the 


lotter on DSK11XQN23PROD with NOTICES1